FGFR1 and cancer: We also found through GSEA analysis of the 33-lncRNA-CESC model are mainly involved in FGFR3 mutant receptor activation, EGFR signaling in GRB2 events, FGFR3 point mutant signaling in cancer, FRS-mediated FGFR1 signaling, EGFR signaling in cancer, downstream signaling in activating FGFR1, and MAP2K and MAPK activation, FGFR1 signaling, Oncogenic MAPK signaling and other signaling pathways.